{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:30Z","timestamp":1792593690374,"version":"4.5.0"},"reference-count":34,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Introduction: co-infection of hepatitis B and C viruses with HIV is associated with poorer survival, increased risk of severe liver disease, and greater highly active antiretroviral therapy (HAART)-related liver toxicity. This study assessed the seroprevalence and risk factors for triple co-infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HBV\/HCV\/HIV) among HIV-positive patients on HAART at the Federal Medical Centre, Makurdi.\n\n \n\nMethods: in this cross-sectional study, 250 HIV-positive adults were recruited consecutively over three months. Socio-demographic data and risk factors were collected using structured questionnaires. Serum samples were analyzed for hepatitis B and C. Prevalence was calculated, and associations with triple co-infection were examined using chi-square and logistic regression analyses (SPSS v27.0, 95% confidence level).\n\n \n\nResults: the prevalence of HBV\/HCV\/HIV triple co-infection was 1.2% among 250 HIV patients receiving HAART. The cohort was predominantly female (74.4%), with a female-to-male ratio of 3:1 and a mean age of 45 years. Secondary education (AOR = 3.080, 95% CI: 1.420-7.038, p = 0.020), multiple sexual partners (AOR = 2.200, 95% CI: 1.271-7.073, p = 0.001), and smoking (AOR = 4.071, 95% CI: 1.101-11.018, p = 0.001) were independent predictors of triple co-infection. No significant associations were observed with sex, age, marital status, employment, alcohol use, or body mass index (BMI).\n\n \n\nConclusion: the 1.2% seroprevalence of triple co-infection is low but highlights the ongoing presence of these infections. This finding reinforces the need for stronger public health education and more targeted screening programs. These measures can help reduce risky behaviors and encourage early testing to curb transmission.<\/jats:p>","DOI":"10.11604\/pamj.2026.54.15.52097","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:03:32Z","timestamp":1792591412000},"source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence and risk factors of HBV\/HCV\/HIV triple co-infection among HIV patients receiving HAART at a Tertiary Hospital in Makurdi, Nigeria"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-7629","authenticated-orcid":false,"given":"Daniel Olagoke","family":"Aina","sequence":"first","affiliation":[{"name":"Acute Medicine, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-9281","authenticated-orcid":false,"given":"Shawon Fredrick","family":"Akpagher","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Jos, Jos, Plateau State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9523-0002","authenticated-orcid":false,"given":"Blessing Onyinye","family":"Kene-Okeke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Benue State University Teaching Hospital, Makurdi, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4785-6586","authenticated-orcid":false,"given":"Abisola Mercy","family":"Olowofeso","sequence":"additional","affiliation":[{"name":"School of Integrated Sciences, Sustainability and Public Health, University of Illinois Springfield, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2092-7833","authenticated-orcid":false,"given":"Anthony Chidiebere","family":"Ohanu","sequence":"additional","affiliation":[{"name":"Public Health Department, University Hospital Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Inedu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, National Orthopedic Hospital, Jos, Plateau State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2924-3688","authenticated-orcid":false,"given":"John Joel","family":"Iji","sequence":"additional","affiliation":[{"name":"Milken Institute School of Public Health, The George Washington University, Washington, D.C., USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-1759","authenticated-orcid":false,"given":"Yanmeer Simeone","family":"Tyotswam","sequence":"additional","affiliation":[{"name":"Department of Population, Reproductive Health and Community Resources Management, Kenyatta University, Kenyatta, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Li M, Cao W, Xie Y. World Hepatitis Day 2025: Progress and Challenges in the Global Elimination of Viral Hepatitis. China CDC Wkly. 2025 Jul 25;7(30):987-990. PubMed | Google Scholar","DOI":"10.46234\/ccdcw2025.167"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Anitah M. Epidemiological trends of HIV\/AIDS in Sub-Saharan Africa: A 2024 perspective. Research Output Journal of Public Health and Medicine. 2024;4(3):1-6. Google Scholar","DOI":"10.59298\/ROJPHM\/2024\/431600"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Dagnaw M, Muche AA, Geremew BM, Gezie LD. Prevalence and burden of HBV-HIV co-morbidity: a global systematic review and meta-analysis. Front Public Health. 2025 Apr 4;13:1565621. PubMed | Google Scholar","DOI":"10.3389\/fpubh.2025.1565621"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kenfack-Momo R, Kenmoe S, Takuissu GR, Ebogo-Belobo JT, Kengne-Nde C, Mbaga DS et al. Epidemiology of hepatitis B virus and\/or hepatitis C virus infections among people living with HIV in Africa: A systematic review and meta-analysis. PLoS One. 2022 May 31;17(5):e0269250. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0269250"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Da Costa S. Estimating the welfare gains from anti-retroviral therapy in Sub-Saharan Africa. J Health Econ. 2023 Jul;90:102777. PubMed | Google Scholar","DOI":"10.1016\/j.jhealeco.2023.102777"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ajii DJ, Nwaburu EC, Idris NA, Yusuf SN, Yawe PM, Akpagher SF. Prevalence and Risk Factors of Hepatitis B among HIV Positive Patients Receiving HAART at Federal Medical Centre Makurdi, Benue State: A Cohort Study. Asian Journal of Medicine and Health. 2025 Jun 9;23(6):154-65. Google Scholar","DOI":"10.9734\/ajmah\/2025\/v23i61250"},{"key":"ref6","unstructured":"National Agency for Control of AIDS (NACA), Federal Ministry of Health. National Strategic Framework on HIV and AIDS: 2017-2021. 2017."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ugah UI, Alo MN, Gloria UC. Epidemiology of hepatitis b virus, hepatitis C virus and human immunodeficiency virus co-infection among assymptomatic persons resident in Alex Ekwueme federal university Ndufu-alike. Scientific African. 2021 Nov 1;14:e00985. Google Scholar","DOI":"10.1016\/j.sciaf.2021.e00985"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Shrestha LB, Yadav GK, Pradhan S, Sharma A, Pandit T, Chhetry R et al. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal. PLoS One. 2022 Mar 3;17(3):e0264791. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0264791"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Shrestha DB, Budhathoki P, Sedhai YR, Shrestha LB, Awal S, Upadhaya Regmi B et al. Prevalence of Hepatitis B and C among HIV Infected Patients in Nepal over 1990-2020. Kathmandu Univ Med J (KUMJ). 2021 Jan.-Mar;19(73):132-139. PubMed | Google Scholar","DOI":"10.3126\/kumj.v19i1.49598"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Bhattarai M, Baniya JB, Aryal N, Shrestha B, Rauniyar R, Adhikari A et al. Epidemiological Profile and Risk Factors for Acquiring HBV and\/or HCV in HIV-Infected Population Groups in Nepal. Biomed Res Int. 2018 Jan 2;2018:9241679. PubMed | Google Scholar","DOI":"10.1155\/2018\/9241679"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"da Silva CM, de Peder LD, Guelere AM, Horvath JD, Silva ES, Teixeira JJV et al. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among HIV-infected patients in an HBV endemic area in Brazil. PLoS One. 2018 Sep 7;13(9):e0203272. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0203272"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Kim JH, Psevdos G, Suh J, Sharp VL. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J Gastroenterol. 2008 Nov 21;14(43):6689-93. PubMed | Google Scholar","DOI":"10.3748\/wjg.14.6689"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Su S, Fairley CK, Sasadeusz J, He J, Wei X, Zeng H et al. HBV, HCV, and HBV\/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome. J Med Virol. 2018 Mar;90(3):518-525. PubMed | Google Scholar","DOI":"10.1002\/jmv.24988"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Pappoe F, Hagan CKO, Obiri-Yeboah D, Nsiah P. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care. BMC Infect Dis. 2019 May 3;19(1):380. PubMed | Google Scholar","DOI":"10.1186\/s12879-019-4027-y"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Boateng R, Mutocheluh M, Dompreh A, Obiri-Yeboah D, Odame Anto E, Owusu M et al. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naive individuals in Kumasi, Ghana. PLoS One. 2019 Apr 19;14(4):e0215377. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0215377"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Maina DN, Nyerere AK, Gicho RW, Mwangi JM, Lihana RW. Prevalence and Factors Associated With Hepatitis B and C Co-Infection Among HIV-1-Infected Patients in Kenya. East Afr Health Res J. 2017;1(2):73-79. PubMed | Google Scholar","DOI":"10.24248\/eahrj.v1i2.552"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Baseke J, Musenero M, Mayanja-Kizza H. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda. Afr Health Sci. 2015 Jun;15(2):322-7. PubMed | Google Scholar","DOI":"10.4314\/ahs.v15i2.3"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J. 2013 May 30;10:171. PubMed | Google Scholar","DOI":"10.1186\/1743-422X-10-171"},{"key":"ref19","unstructured":"Oluremi AS, Opaleye OO, Babalola BA, Shittu M, Abayomi O. Coinfection of Hepatitis B and C virus among HIV patients visiting specialist hospital in Ikole Ekiti, Nigeria. J Med Sci Clin Res. 2014;2(11):2933-2939. Google Scholar"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009 Jun 1;3(5):369-75. PubMed | Google Scholar","DOI":"10.3855\/jidc.245"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Anyanwu NCJ, Sunmonu PT, Mathew MH. Viral hepatitis B and C co-infection with HIV among adult patients attending selected HAART clinics in Nigeria's capital. J Immunoassay Immunochem. 2020;41(2):171-183. PubMed | Google Scholar","DOI":"10.1080\/15321819.2019.1705852"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Inyang-Etoh PC, Eyo GO, Philip-Ephraim EE. Occurrence of hepatitis \"B\" and \"C\" amongst patients on antiretroviral drug therapy (ART) in a treatment centre in Calabar, Nigeria. Int J Med Med Sci. 2014;6(6):158-160. Google Scholar","DOI":"10.5897\/IJMMS2014.1037"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Erasmus MA, Akani NP, Amadi LO, Williams JO. The prevalence of hepatitis B and C among HIV positive patients in some hospitals in rivers state. J Adv Microbiol. 2021;21(8):1-8. Google Scholar","DOI":"10.9734\/jamb\/2021\/v21i830371"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ojide CK, Kalu EI, Ogbaini-Emevon E, Nwadike VU. Co-infections of hepatitis B and C with HIV among adult patients attending HIV outpatients clinic in Benin City, Nigeria. Niger J Clin Pract. 2015 Jul-Aug;18(4):516-21. PubMed | Google Scholar","DOI":"10.4103\/1119-3077.151790"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Nnakenyi ID, Uchechukwu C, Nto-Ezimah U. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria. Afr Health Sci. 2020 Jun;20(2):579-586. PubMed | Google Scholar","DOI":"10.4314\/ahs.v20i2.5"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Gamawa ZR, Shehu K, Moi IM, Abubakar BM. Seroprevalence and Risk Factors of Hepatitis B and C Co-infection and Their Correlation with CD4 Cells and Liver Enzymes in HIV Patients at a Teaching Hospital in Nigeria. SN Compr Clin Med. 2024;7:20. Google Scholar","DOI":"10.1007\/s42399-025-01778-7"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE et al. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Mem Inst Oswaldo Cruz. 2007 Jun;102(4):535-7. PubMed | Google Scholar","DOI":"10.1590\/S0074-02762007005000025"},{"key":"ref28","unstructured":"Muktar H, Alkali C, Jones E. Hepatitis B and C co-infections in HIV\/AIDS patients attending ARV center ABUTH, Zaria, Nigeria. Highland Med Res J. 2006;4(1):39-45. Google Scholar"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Chihota BV, Riebensahm C, Muula G, Sinkala E, Chilengi R, Mulenga L et al. Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia. BMJ Open Gastroenterol. 2022 Jul;9(1):e000945. PubMed | Google Scholar","DOI":"10.1136\/bmjgast-2022-000945"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009 May;49(5 Suppl):S138-45. PubMed | Google Scholar","DOI":"10.1002\/hep.22883"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Zajacova A, Lawrence EM. The Relationship Between Education and Health: Reducing Disparities Through a Contextual Approach. Annu Rev Public Health. 2018 Apr 1;39:273-289. PubMed | Google Scholar","DOI":"10.1146\/annurev-publhealth-031816-044628"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Adesegun OA, Olaniran OH, Bamidele E, Inyang JN, Adegbe M, Binuyo TO et al. HIV-hepatitis co-infection in a rural community in Northern Nigeria. The Pan African Medical Journal. 2020 Aug 27;36:352. PubMed | Google Scholar","DOI":"10.11604\/pamj.2020.36.352.23978"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Breen RWB, Parmley LE, Mapingure MP, Chingombe I, Mugurungi O, Musuka G et al. Hepatitis B virus infection (HBV) and HIV-HBV coinfection among men who have sex with men, transgender women, and genderqueer individuals in Harare and Bulawayo Zimbabwe, 2019. Heliyon. 2024 Feb 3;10(3):e25790. PubMed | Google Scholar","DOI":"10.1016\/j.heliyon.2024.e25790"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:03:46Z","timestamp":1792591426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/54\/15\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":34,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.54.15.52097","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"52097"}}